Beam Therapeutics Inc (BEAM)

94.35 +2.56  +2.79% NASDAQ Oct 28, 16:00 94.35 0.00  0.00% After-Hours: 17:11 USD
View Full Chart
Price Chart
View All BEAM News


View All Events


Date Type Description
11/10/2021 Earnings Results Q3 2021 Earnings Results
08/10/2021 Earnings Results Q2 2021 Earnings Results
06/09/2021 11:30 EST AGM 2020 Annual General Meeting
05/11/2021 Earnings Results Q1 2021 Earnings Results
03/15/2021 Earnings Results Q4 2020 Earnings Results
11/10/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.
  • URL:
  • Investor Relations URL:
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Nov. 10, 2021
  • Last Earnings Release: Aug. 10, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
F00001C7ZQ GUGG ARK Early Stage Disruptors 1 CA 4.23%
F00001C7ZN GUGG ARK Erly Stg Dsrptrs CDA 2021 Q3CA 4.23%
ARKG ARK Genomic Revolution ETF 2.95%
EAGB.NO Emerge ARK Genomics & Biotech ETF 2.46%
ARKK ARK Innovation ETF 2.43%
EARK.NO Emerge ARK Global Disruptive Innovt ETF 2.19%
IBBJ Defiance Nasdaq Junior Biotechnology ETF 2.01%
HELX Franklin Genomic Advancements ETF 1.30%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.